Paper Details

  1. Home
  2. Paper Details

Influenza virus neuraminidase inhibitors.

Author: GubarevaL V, HaydenF G, KaiserL

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Neuraminidase inhibitors, such as zanamivir and oseltamivir, are effective treatments for influenza A and B viruses. They are well-tolerated and have a broader antiviral spectrum than amantadine and rimantadine.
Paper Details　
Original Abstract of the Article :
Neuraminidase promotes influenza virus release from infected cells and facilitates virus spread within the respiratory tract. Several potent and specific inhibitors of this enzyme have been developed, and two (zanamivir and oseltamivir) have been approved for human use. Unlike amantadine and rimanta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S0140-6736(99)11433-8

データ提供：米国国立医学図書館（NLM）

The Power of Neuraminidase Inhibitors in Fighting Influenza

Influenza, a relentless enemy, has been the focus of extensive research. This study explores the effectiveness of neuraminidase inhibitors, like zanamivir and oseltamivir, in combating influenza virus infections. These inhibitors are like skillful travelers, blocking the virus's path and preventing its spread through the respiratory tract.

A New Frontier in Influenza Treatment

This research highlights the effectiveness of neuraminidase inhibitors in reducing the severity and duration of influenza symptoms. These inhibitors offer a novel approach to combating influenza, like a fresh oasis in the desert of viral infections. The study's findings suggest that these inhibitors may be a valuable addition to the arsenal of antiviral treatments.

Staying Ahead of the Flu

The emergence of influenza each year is like a desert storm, unpredictable and potentially disruptive. This research provides valuable insights into the use of neuraminidase inhibitors, offering us a better understanding of how to combat this seasonal threat.

Dr.Camel's Conclusion

This study is like a beacon of hope in the desert of influenza, highlighting the potential of neuraminidase inhibitors to combat this relentless foe. By providing insights into their effectiveness and mechanisms of action, this research equips us with valuable tools to navigate the seasonal flu and protect our health.

Date :
  1. Date Completed 2000-03-21
  2. Date Revised 2015-06-16
Further Info :

Pubmed ID

10711940

DOI: Digital Object Identifier

10.1016/S0140-6736(99)11433-8

Related Literature

Article Analysis
・Effects of zanamivir oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.